Explainer
How Long Does Naltrexone Stay in Your System?
Half-life, how long the opioid block lasts, drug tests and stopping before surgery, for the tablet and the monthly shot.
By Naltrexone Reviews Editorial TeamUpdated 13 sourcesHow we check

On this page
Short answer
A naltrexone tablet has a half-life of about 4 hours (13 for its metabolite) and blocks opioids for up to 24 hours; the Vivitrol shot's half-life is 5 to 10 days, and its block lasts about 28 days.1,2 Federal workplace drug tests don't include naltrexone, and SAMHSA advises stopping tablets 3 days and Vivitrol 30 days before surgery needing opioids.3,4
Key takeaways
- The block outlasts the tablet's half-life. The label credits the effect to both naltrexone and its longer-lasting metabolite, 6-β-naltrexol.1
- Tablets don't build up. Naltrexone and 6-β-naltrexol do not accumulate on daily 100 mg doses.1
- Vivitrol levels peak twice, at about 2 hours and again 2–3 days after the shot, then start a slow decline around day 14.2
- Vivitrol can't be taken out. Once injected, "it is not possible to remove it from the body."2
- Liver disease can raise levels a lot. With tablets, exposure was about 5 times higher in compensated and 10 times higher in decompensated cirrhosis.1
- A false positive is possible but rarely reported. Two case reports describe naltrexone tablets setting off an oxycodone screen; follow-up lab testing found no oxycodone.5,6
- Surgery guidance agrees on stopping but rests on thin evidence. All 13 guideline documents in a 2024 review advised stopping naltrexone before surgery; none was built on a systematic evidence search.7
- Safety: when the block wears off, people who used opioids before can overdose on smaller doses than they used to.1,2
At a glance
| Attribute | Naltrexone tablets (50 mg) | Vivitrol (380 mg injection) |
|---|---|---|
| How it's taken | By mouth; 50 mg once daily for most patients with alcohol dependence1 | Injection into the buttock muscle every 4 weeks or once a month2 |
| Peak blood level | Within 1 hour1 | About 2 hours, then a second peak about 2–3 days later2 |
| Half-life of naltrexone | About 4 hours (mean)1 | 5–10 days2 |
| Half-life of 6-β-naltrexol | About 13 hours (mean)1 | 5–10 days2 |
| Opioid blockade | Up to 24 hours (50 mg)1 | About 28 days2 |
| Still measurable in blood | Low levels at 72 hours after a 100 mg dose (study of 4 people)8 | "greater than 1 month"2 |
| Builds up with repeat doses? | No (at 100 mg daily)1 | Minimal (<15%)2 |
| On the federal workplace drug panel? | No3 | No3 |
| Stop before planned surgery (SAMHSA) | At least 3 days4 | 30 days4 |
How long naltrexone lasts, by form, from the two FDA labels.
How it's taken
Peak blood level
Half-life of naltrexone
Half-life of 6-β-naltrexol
Opioid blockade
Still measurable in blood
Builds up with repeat doses?
On the federal workplace drug panel?
Stop before planned surgery (SAMHSA)
Three different questions
"How long does it stay in your system?" can mean three things, and each has a different answer.
- How long is it in your blood? This is what half-life describes. Neither label says when naltrexone is completely gone. A common "5 half-lives" rule of thumb is not in either label, so we don't use it here.
- How long does it keep working? For naltrexone, "working" means blocking opioids. The labels give blockade times that are longer than the tablet's half-life.1,2 When it starts to help with drinking is a different question, answered on how long naltrexone takes to work.
- How long would a test find it? That depends on what the test looks for. See drug tests.
Naltrexone tablets (oral)
Getting in. About 96% of a dose is absorbed from the gut, and blood levels of naltrexone and 6-β-naltrexol peak within an hour.1
First pass through the liver. Much of each dose is broken down on its first pass through the liver, so only an estimated 5% to 40% reaches the bloodstream unchanged. The main breakdown product, 6-β-naltrexol, is active too, and the label attributes naltrexone's effect to both compounds.1
Half-life. "The mean elimination half-life (T-1/2) values for naltrexone and 6-β-naltrexol are 4 hours and 13 hours, respectively."1 These are two different compounds. Naltrexone's own half-life is about 4 hours, not "4 to 13 hours."
Leaving the body.
- More than 98% of naltrexone is metabolized (changed into other compounds).1
- Naltrexone and its metabolites leave mainly through the kidneys (53% to 79% of the dose). Less than 2% of a dose comes out in urine as unchanged naltrexone. About 43% comes out in urine as 6-β-naltrexol (unchanged or conjugated).1
- Naltrexone and its metabolites "may undergo enterohepatic recycling," meaning they may be passed into the gut and reabsorbed.1
How long the block lasts. "Clinical studies indicate that 50 mg of naltrexone hydrochloride will block the pharmacologic effects of 25 mg of intravenously administered heroin for periods as long as 24 hours." Other data cited in the label suggest a double dose blocks for 48 hours and a triple dose for about 72 hours.1 Those longer schedules (such as 100 mg every other day or 150 mg every third day) are options in supervised settings, but the label warns that the block "may be reduced by these extended dosing intervals."1 Dosing is your prescriber's call; see naltrexone dosage.
Vivitrol (monthly injection)
Vivitrol is an extended-release form of naltrexone in tiny polymer microspheres, injected into the buttock muscle every 4 weeks or once a month.2
Levels over the month. Blood levels peak briefly about 2 hours after the shot and again about 2–3 days later. From about day 14 they slowly decline, "with measurable levels for greater than 1 month."2
Half-life. The half-life of naltrexone after a Vivitrol shot is 5 to 10 days and depends on how fast the polymer breaks down. The half-life of 6β-naltrexol is also 5 to 10 days.2
Blockade. Vivitrol "blocks the effects of exogenous opioids for approximately 28 days after administration."2
More total drug, less metabolite. One 380 mg shot gives 3 to 4 times more total naltrexone exposure than 28 days of 50 mg tablets. Repeat shots build up only minimally (<15%). Because less of the dose is broken down on a first pass through the liver, much less 6β-naltrexol is made than with tablets.2
It can't be removed. The label tells prescribers to explain that "once VIVITROL is injected, it is not possible to remove it from the body."2
For more on the shot, see Vivitrol (naltrexone injection) · Naltrexone vs Vivitrol · Vivitrol side effects.
What can change how long it lasts
| Factor | Tablets | Vivitrol |
|---|---|---|
| Liver disease | Exposure (AUC) about 5× higher in compensated and 10× higher in decompensated cirrhosis1 | Not changed in mild to moderate liver impairment; not studied in severe2 |
| Kidney disease | Caution recommended in kidney impairment1 | Not changed in mild kidney impairment; not studied in moderate or severe, where caution is recommended2 |
| Dose | Higher doses give longer blockade (48 hours at 2×, about 72 hours at 3×)1 | One dose strength: 380 mg2 |
| Sex | Not stated | Did not affect levels in a study of 18 women and 18 men2 |
| Age | Not stated | Not studied in children or older adults2 |
| Other medicines (CYP enzymes) | Not stated | Naltrexone is not broken down by CYP enzymes, so drugs that change those enzymes "are unlikely to change the clearance of VIVITROL"2 |
What the labels say can change naltrexone levels or the length of the opioid block.
Factor: Liver disease
Factor: Kidney disease
Factor: Dose
Factor: Sex
- Tablets
- Not stated
- Vivitrol
- Did not affect levels in a study of 18 women and 18 men2
Factor: Age
- Tablets
- Not stated
- Vivitrol
- Not studied in children or older adults2
Factor: Other medicines (CYP enzymes)
- Tablets
- Not stated
- Vivitrol
- Naltrexone is not broken down by CYP enzymes, so drugs that change those enzymes "are unlikely to change the clearance of VIVITROL"2
If you have liver or kidney disease, ask your prescriber what this means for you. See also Naltrexone and liver tests (ALT/AST).
Will naltrexone show up on a drug test?
Not on the standard federal panel, because that panel doesn't look for it. The federal workplace drug-testing panel, which HHS republished in March 2026, covers marijuana, cocaine, a set of opioids (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, heroin's marker 6-acetylmorphine, and fentanyl), PCP, and amphetamines including MDMA. Naltrexone and 6-β-naltrexol are not on it.3 That panel is set for federal workplace programs. If your test is for another employer, a clinic or a court, ask what it covers.
A false positive for oxycodone has been reported, rarely. Both labels hedge: tablets "may or may not interfere" with enzyme-based opioid tests, depending on the test, and Vivitrol "may be cross-reactive" with certain urine opioid immunoassays, so check the test maker's instructions.1,2 In a 2024 case report, a man taking 50 mg tablets screened positive for oxycodone three times while his standard opiates screen stayed negative. Confirmatory testing found no oxycodone, but did find noroxymorphone, a minor naltrexone breakdown product that is also made when the body breaks down oxycodone.5 An earlier case report described the same pattern.6 One pathology lab's guide to its opiate screen lists high naltrexone levels as a possible cause of false positives.9 Confirmatory testing, which identifies specific drugs, is what sorts these results out, and the federal panel pairs each screen with a confirmatory test for named drugs.3,5
A lab can find naltrexone when it's asked to. Mass-spectrometry methods can measure naltrexone and 6-β-naltrexol in urine below 1 ng/mL. One was developed to check whether people on court-ordered alcohol treatment in South Korea were taking their medicine.10
No published detection window. We found no study that says how many hours or days naltrexone stays detectable in urine, blood, saliva or hair. The nearest data are small studies from the 1970s. In patients taking 125 mg of naltrexone three times a week, 34% of a dose appeared in urine within 24 hours and 3% in the following 24 hours, mostly as 6-β-naltrexol.11 In 4 people given 100 mg, low blood levels of naltrexone were still present at 72 hours.8 Those numbers describe how the drug leaves the body. They do not tell you how long any particular test stays positive.
Carry ID. Both labels advise carrying identification or documentation that shows you take naltrexone, so medical staff know in an emergency.1,2
Stopping naltrexone before surgery
Why it matters. While naltrexone is blocking, opioid pain medicine may not work as expected. "In a situation requiring opioid analgesia, the amount of opioid required may be greater than usual, and the resulting respiratory depression may be deeper and more prolonged."1 Opioid-containing cough, cold and diarrhea medicines may not work either.1 After naltrexone is stopped, the opposite can happen: an anesthesia review notes that people may become more sensitive to opioids.12
Guidance agrees on stopping, not on exact timing. A 2024 scoping review by the Perioperative Pain and Addiction Interdisciplinary Network found 13 guideline documents. All recommended stopping naltrexone before surgery, whatever the dose, reason or form, but none was built on a systematic literature search or a formal expert-consensus method.7 Two examples:
| Attribute | Tablets | Vivitrol |
|---|---|---|
| SAMHSA advisory, 2021 (US) | Stop at least 3 days before planned opioid treatment | Stop 30 days before; take tablets until about 3 days before the procedure |
| Anesthesia review, 2023 (Australia) | Stop at least 24 hours, ideally 72 hours, before | Stop at least 25 days before; tablets may bridge the gap, stopped 72 hours before |
| Restarting (SAMHSA) | 3–7 days after the last prescribed opioid | 3–7 days after the last prescribed opioid |
What guidance says about stopping naltrexone before surgery, by form.
SAMHSA advisory, 2021 (US)
- Tablets
- Stop at least 3 days before planned opioid treatment
- Vivitrol
- Stop 30 days before; take tablets until about 3 days before the procedure
Anesthesia review, 2023 (Australia)
- Tablets
- Stop at least 24 hours, ideally 72 hours, before
- Vivitrol
- Stop at least 25 days before; tablets may bridge the gap, stopped 72 hours before
Restarting (SAMHSA)
- Tablets
- 3–7 days after the last prescribed opioid
- Vivitrol
- 3–7 days after the last prescribed opioid
Sources: SAMHSA4; Whately and Stead.12 The Australian review adds that the gap may need to be longer with kidney or liver impairment, and that staying on naltrexone can be reasonable for procedures expected to cause little pain, such as cataract surgery or colonoscopy, decided case by case with the prescriber.12
Stopping has its own risk. A 2024 review for anesthesiologists says that patients who continue or stop naltrexone around surgery "are at an increased risk for undertreated pain or substance use relapse."13 The scoping review concluded that, for people at risk of returning to opioids or alcohol, stopping "should have a strong rationale."7 Plan the timing with both your surgical team and your naltrexone prescriber.
Emergency surgery or injury. For people on Vivitrol, the label suggests regional anesthesia or non-opioid pain medicine. If opioids are needed, the person should be continuously monitored in an anesthesia care setting.2 SAMHSA's options for people on naltrexone include acetaminophen or ibuprofen for mild pain, regional anesthesia, and general anesthesia without opioids.4
Low-dose naltrexone is handled separately. The Australian review gives LDN, an off-label use at a fraction of the 50 mg dose, its own advice.12 See surgery on LDN.
When the block wears off
"As the blockade of exogenous opioids provided by naltrexone hydrochloride wanes and eventually dissipates completely, patients who have been treated with naltrexone hydrochloride may respond to lower doses of opioids than previously used."1 For Vivitrol, the label flags the end of the month after a shot, or a missed dose, as risky times.2 Both labels tell prescribers to discuss opioid overdose reversal agents such as naloxone.1,2 See Naltrexone vs naloxone.
Starting naltrexone after opioids. This is the reverse question: how long opioids need to be out of your system before naltrexone. The tablet label recommends at least 7 to 10 opioid-free days after short-acting opioids, and up to two weeks for people switching from buprenorphine or methadone.1
What about low-dose naltrexone (LDN)?
Off-label
Low-dose naltrexone is not an FDA-approved use or dose. The FDA labels used on this page do not describe LDN, so they say nothing about how long it stays in your system.
See low-dose naltrexone. Side effects at LDN doses, and what trials saw when people stopped, are on low-dose naltrexone side effects.
Frequently asked questions
How long does naltrexone stay in your system?
In the blood, tablets have a mean half-life of about 4 hours (13 hours for the active metabolite), and Vivitrol 5 to 10 days. One tablet blocks opioids for up to 24 hours, and the shot for about 28 days. See At a glance.1,2
How long does one 50 mg naltrexone pill last?
The label says 50 mg blocks the effects of an IV heroin dose for up to 24 hours.1
How long does Vivitrol stay in your system?
Levels start a slow decline about 14 days after the shot and stay measurable for more than a month; the opioid block lasts about 28 days.2
How long does naltrexone block alcohol?
The labels don't give a time. The 24-hour and 28-day figures are for blocking opioids, not alcohol. The tablet label says the way naltrexone works in alcohol dependence "is not understood," and its alcohol studies used 50 mg once daily. See Naltrexone and alcohol.1
Will naltrexone make me fail a drug test?
It isn't on the federal workplace panel. Two case reports describe a false-positive oxycodone screen on naltrexone tablets that confirmatory testing cleared. See drug tests.3,5,6
Can Vivitrol be removed if I change my mind?
No. The label says "once VIVITROL is injected, it is not possible to remove it from the body."2
What happens if you just stop taking naltrexone?
The labels say naltrexone does not cause physical or psychological dependence. Their main warning about stopping is for people who used opioids before: once the block fades, a smaller opioid dose than before could cause an overdose. Talk with your prescriber before stopping.1,2
How long does low-dose naltrexone stay in your system?
Low-dose naltrexone is an off-label use. The FDA labels don't cover it, so this page gives no figure for it.
Related guides
References
13 sources, numbered in the order they are first cited (AMA style). Each is labelled by type so you can weigh it; commercial and media sources are never the only support for a clinical claim.
- 1.Naltrexone hydrochloride tablets USP, 50 mg. Prescribing information. SpecGx LLC; revised May 2026. DailyMed SPL version 15. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06ff2d5a-e62b-4fa4-bbdb-01938535bc65FDA drug label
- 2.Vivitrol (naltrexone for extended-release injectable suspension). Prescribing information. Alkermes, Inc.; revised May 2026. DailyMed SPL version 39. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703fFDA drug label
- 3.Substance Abuse and Mental Health Services Administration. Mandatory Guidelines for Federal Workplace Drug Testing Programs—Authorized Testing Panels. Fed Regist. 2026;91:12308-12311. Published March 13, 2026. Accessed October 17, 2026. https://www.federalregister.gov/documents/2026/03/13/2026-04981/mandatory-guidelines-for-federal-workplace-drug-testing-programs-authorized-testing-panelsGovernment source
- 4.Substance Abuse and Mental Health Services Administration. Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder. Advisory. Publication No. PEP20-02-02-015. SAMHSA; 2021. Accessed October 17, 2026. https://library.samhsa.gov/sites/default/files/PEP20-02-02-015.pdfClinical guideline
- 5.Beauregard ER, Maguire EG. Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications. Ment Health Clin. 2024;14(2):102-106. doi:10.9740/mhc.2024.04.102Research study · Our summary of this study
- 6.Stanciu CN, Gnanasegaram S. Naltrexone and its noroxymorphone minor metabolite—a case report. J Psychoactive Drugs. 2020;52(2):169-171. doi:10.1080/02791072.2019.1649507Research study · Our summary of this study
- 7.Goel A, Kapoor B, Wu M, et al. Perioperative naltrexone management: a scoping review by the Perioperative Pain and Addiction Interdisciplinary Network. Anesthesiology. 2024;141(2):388-399. doi:10.1097/ALN.0000000000005040Narrative review
- 8.Verebey K, Volavka J, Mulé SJ, Resnick RB. Naltrexone: disposition, metabolism, and effects after acute and chronic dosing. Clin Pharmacol Ther. 1976;20(3):315-328. doi:10.1002/cpt1976203315Research study · Our summary of this study
- 9.Sullivan Nicolaides Pathology. Evaluation of opiate results. Interpretive protocol IP248. January 2020. Accessed October 17, 2026. https://protocols.sonichealthcare.com/shared/IP248.pdfCommercial source · Pathology laboratory's interpretive protocol (Australia).
- 10.Kim SY, Shin DW, Suh S, Cheong JC, Kim JY. Monitoring alcohol-use-disorder medication compliance by LC-MS/MS determination of urinary ethyl glucuronide, acamprosate, naltrexone, and 6β-naltrexol using zirconia-based hybrid solid-phase extraction. J Pharm Biomed Anal. 2022;212:114615. doi:10.1016/j.jpba.2022.114615Research study · Our summary of this study
- 11.Dayton HE, Inturrisi CE. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat. Drug Metab Dispos. 1976;4(5):474-478.Research study · No DOI when the article was printed; Elsevier registered this one for the journal's archive (Crossref, checked October 17, 2026). PubMed 10147. · Our summary of this study
- 12.Whately Y, Stead M. Perioperative management of patients on naltrexone. In: Cheung B, ed. Australasian Anaesthesia 2023. Australian and New Zealand College of Anaesthetists; 2023:102-111. doi:10.60115/11055/1180Narrative review
- 13.Lane O, Ambai V, Bakshi A, Potru S. Alcohol use disorder in the perioperative period: a summary and recommendations for anesthesiologists and pain physicians. Reg Anesth Pain Med. 2024;49(9):621-627. doi:10.1136/rapm-2023-104354Narrative review
Medical disclaimer
This page is for general information only and is not medical advice. It does not replace advice from your own clinician or pharmacist. Don't start, stop, or change a medicine without talking to your prescriber. If you think someone is having an opioid overdose, call 911.
Full medical disclaimer.